NENTER

The company's operational footprint includes three production plants located in Jingzhou, Hubei, collectively spanning approximately 139 acres. Nenter's business is structured around the development, production, and sale of two main product lines. The first series consists of medical intermediates, with a focus on components for montelukast sodium, used in asthma and anti-allergy treatments, and intermediates for rosuvastatin, which is applied in managing hyperlipidemia and high cholesterol. The second product series is centered on Vitamin E and its derivatives. The company also produces other intermediates for products like Minoxidil, as well as chiral chemicals.

Nenter serves a global clientele, with sales markets spanning across Africa, the Americas, Asia, Europe, and Oceania. The company's business model is rooted in the large-scale production and B2B sales of its chemical and pharmaceutical products to a worldwide market. To ensure product standards, Nenter has implemented a quality management system aligned with GMP principles and has secured certifications such as ISO9001:2008, PMDA, USFDA, and FAMI-QS.